Antiangiogenic effect of propranolol on the growth of the neuroblastoma xenografts in nude mice

Journal of Pediatric Surgery

Volumn 48, Issue 12, 2013, Pages 2460-2465

  Xu, Ting ^a   Xiao, Xianmin ^a   Zheng, Shan ^a   Zheng, Jicui ^a   Zhu, Haitao ^a   Ji, Yi ^a   Yang, Shaobo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Microvessel density; Neuroblastoma; Propranolol; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; METALLOPROTEINASE; PROPRANOLOL; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; BODY WEIGHT; CANCER INHIBITION; CAPILLARY DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANGIOGENESIS; MICROVESSEL DENSITY; NEUROBLASTOMA; PROPRANOLOL; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROVESSELS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROPRANOLOL; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84889577135     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2013.08.022     Document Type: Conference Paper

References (35)

1. J.C. Hoehner, C. Gestblom, and F. Hedborg A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage Lab Invest 75 1996 659 675
2. J.M. Maris, M.D. Hogarty, and R. Bagatell Neuroblastoma Lancet 369 2007 2106 2120
3. B. De Bernardi, B. Nicolas, and L. Boni Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma J Clin Oncol 21 2003 1592 1601
4. K.K. Matthay, J.G. Villablanca, and R.C. Seeger Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 1999 1165 1173
5. C. Leaute-Labreze, E. Dumas de la Roque, and T. Hubiche Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651
6. A.L. Marqueling, V. Oza, and I.J. Frieden Propranolol and infantile hemangiomas four years later: a systematic review Pediatr Dermatol 30 2013 182 191
7. C.H. Storch, and P.H. Hoeger Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Br J Dermatol 163 2010 269 274
8. Y. Ji, K. Li, and X.M. Xiao Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells J Pediatr Surg 47 2012 2216 2223
9. S. Lamy, M.P. Lachambre, and S. Lord-Dufour Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells Vascul Pharmacol 53 2010 200 208
10. A. Glasner, R. Avraham, and E. Rosenne Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor J Immunol 184 2010 2449 2457
11. E.V. Yang, A.K. Sood, and M. Chen Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells Cancer Res 66 2006 10357 10364
12. F. Hajighasemi, and S. Hajighasemi Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro Iran Biomed J 13 2009 223 228
13. J. Grunberg, I. Novak-Hofer, and M. Honer In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors Clin Cancer Res 11 2005 5112 5120
14. K. Zhang, and P.K. Chow The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo Clin Cancer Res 10 2004 5226 5232
15. S.W. Cole, and A.K. Sood Molecular pathways: beta-adrenergic signaling in cancer Clin Cancer Res 18 2012 1201 1206
16. T.I. Barron, R.M. Connolly, and L. Sharp Beta blockers and breast cancer mortality: a population- based study J Clin Oncol 29 2011 2635 2644
17. D.G. Powe, M.J. Voss, and K.S. Zanker Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival Oncotarget 1 2010 628 638
18. E. Pasquier, J. Ciccolini, and M. Carre Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment Oncotarget 2 2010 797 809
19. D. Palm, K. Lang, and B. Niggemann The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers Int J Cancer 118 2006 2744 2749
20. J.W. Lee, M.M. Shahzad, and Y.G. Lin Surgical stress promotes tumor growth in ovarian carcinoma Clin Cancer Res 15 2009 2695 2702
21. X. Lin, K. Luo, and Z. Lv Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice Hepatogastroenterology 59 2012 584 588
22. N. Bonnet, C.L. Benhamou, and L. Malaval Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions J Cell Physiol 217 2008 819 827
23. D. Meitar, S.E. Crawford, and A.W. Rademaker Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma J Clin Oncol 14 1996 405 414
24. D.W. Leung, G. Cachianes, and W.J. Kuang Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309
25. D. Ribatti, D. Marimpietri, and F. Pastorino Angiogenesis in neuroblastoma Ann N Y Acad Sci 1028 2004 133 142
26. W. Cruz-Munoz, and R. Khokha The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis Crit Rev Clin Lab Sci 45 2008 291 338
27. R. Ezhilarasan, U. Jadhav, and I. Mohanam The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice Int J Cancer 124 2009 306 315
28. Y. Sugiura, H. Shimada, and R.C. Seeger Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis Cancer Res 58 1998 2209 2216
29. T. Ara, M. Fukuzawa, and T. Kusafuka Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome J Pediatr Surg 33 1998 1272 1278
30. G. Bergers, R. Brekken, and G. McMahon Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 2000 737 744
31. S. Modak, and N.K. Cheung Neuroblastoma: therapeutic strategies for a clinical enigma Cancer Treat Rev 36 2010 307 317
32. S. Roy Choudhury, S. Karmakar, and N.L. Banik Targeting angiogenesis for controlling neuroblastoma J Oncol 2012 2012 782020
33. J.M. Ebos, C.R. Lee, and R.S. Kerbel Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy Clin Cancer Res 15 2009 5020 5025
34. G. des Guetz, B. Uzzan, and K. Chouahnia Cardiovascular toxicity of anti-angiogenic drugs Target Oncol 6 2011 197 202
35. B.A. Drolet, P.C. Frommelt, and S.L. Chamlin Initiation and use of propranolol for infantile hemangioma: report of a consensus conference Pediatrics 131 2013 128 140